Cancer mortality in trials of heart failure with reduced ejection fraction: a systematic review and meta‐analysis

G Tini, E Bertero, A Signori, MP Sormani… - … of the American Heart …, 2020 - Am Heart Assoc
… of RCTs as well as of the investigations about comorbid cancer. , … heart failure; and VHeFT
II, vasodilatorheart failure trial II. … of enalapril on mortality in severe congestive heart failure. …

2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
… pharmacological treatments, including doses of diuretics. Observational studies have shown
… to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure) investigators

The Chronic Systolic Heart Failure Patient: Presentation and Management

A Bitar, KD Aaronson - … for End‐Stage Heart and Lung Disease, 2023 - Wiley Online Library
… II–III) were randomized to enalapril or placebo, enalapril was … Cooperative VasodilatorHeart
Failure Trial (V-HeFT I) the … ) and PRAISE-2 trials and felodipine in V-HeFT III did not affect …

2022 ACC/AHA/HFSA guideline for the management of heart failure

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - … of Cardiac Failure, 2022 - Elsevier
… pharmacological treatments, including doses of diuretics. Observational studies have shown
… to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure) investigators

[PDF][PDF] 3. 1. b. Class Ill antiarrhythmic agents

E CAL, I ENTION - The arrhythmia risk profile in left ventricular dysfunction … - research.rug.nl
… Nevertheless, newer calcium channel blockers such as felodipine and … enalapril with
hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure (V-HeFT